Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada
2022 · Archives of Osteoporosis · 13 citations
https://doi.org/10.1007/s11657-022-01106-9
B
Ben Johnson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
561
Citations
11
h-index
11
i10-index
Ben Johnson is an academic researcher from Kyowa Kirin International (United Kingdom). The author has contributed to research in topics: Parathyroid Disorders and Treatments & Bone health and osteoporosis research & Bone health and treatments. The author has an h-index of 11, co-authored 24 publications.
ORCID: 0000-0003-3938-0920Papers by this author
worksReal-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
2021 · Archives of Osteoporosis · 9 citations
https://doi.org/10.1007/s11657-021-01020-6
Health-related quality of life and productivity burden for non-professional caregivers of adults with rare diseases: a real-world study
2025 · Orphanet Journal of Rare Diseases · 1 citations
https://doi.org/10.1186/s13023-025-03796-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat